Yuri Deigin, co-founder of Youth Biotherapeutics and a key voice in COVID-19 origin debates, dives deep into the contentious lab leak hypothesis. He examines the pros and cons of COVID vaccines, discussing how viral mutations impact their effectiveness. The conversation explores whether early instances of COVID's spread point to a lab-origin rather than zoonotic sources. Deigin critiques the role of the Wuhan market and unpacks the complexities of COVID's lineages, revealing intriguing insights into virology research collaboration between the US and China.

Yuri Deigin, CEO of YouthBio Therapeutics and a visionary in longevity science, dives into the revolutionary potential of partial reprogramming gene therapies aimed at rejuvenating not just cells, but entire organisms. He shares insights about tackling aging as the root cause of diseases, the complexities of epigenetics, and advances in Alzheimer’s treatments. The conversation highlights ethical considerations, the challenges of funding biotech innovations, and the exciting prospects of extending lifespans through scientific discovery.